Cardiff Oncology Cash Flow Statement (2011-2025) | CRDF

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Operating Activities
Net Income (Quarter)	-5.44M	-6.89M	-7.00M	-9.53M	-11.07M	-10.44M	-8.99M	-9.39M	-12.05M	-11.15M	-9.75M	-9.32M	-10.01M	-11.74M	-11.86M	-11.79M	-13.44M	-13.94M	-11.26M	-7.21M
Depreciation and Depletion (Quarter)														0.10M	0.10M	0.09M		0.09M	0.09M	0.12M
Share-based Compensation (Quarter)	0.27M	1.04M	0.94M	0.99M	1.15M	1.05M	1.04M	1.01M	1.06M	1.58M	0.95M	0.91M	1.12M	1.18M	1.25M	1.20M	1.36M	1.68M	1.38M	1.26M
Gains from Investment Securities (Quarter)												6.65M			8.35M	8.33M	0.67M	293.00	4.71M	4.93M
Cash from Restructuring (Quarter)
Non-cash Items (Quarter)												0.02M			4.43M	11.67M	5.45M	4.76M	6.33M	9.80M
Cash from Operations (Quarter)	-5.88M	-4.30M	-5.46M	-7.39M	-10.25M	-6.70M	-7.49M	-9.39M	-8.66M	-7.13M	-7.96M	-7.14M	-7.74M	-9.23M	-10.46M	-10.27M	-12.79M	-8.33M	-10.83M	-5.97M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)	-0.20M	-0.49M	-0.46M	-0.45M	-0.35M	-0.21M	-0.12M	0.04M	0.16M	0.24M	0.31M	0.20M	0.16M	0.11M	0.17M	0.10M	0.14M	0.13M	0.14M	0.14M
Amortization of Deferred Charges (Quarter)
Depreciation & Amortization (CF) (Quarter)	0.12M	0.11M	0.11M	0.11M	0.03M	0.04M	0.08M	0.09M	0.09M	0.10M	0.11M	0.10M	0.10M	0.10M	0.10M	0.10M	0.09M	0.09M	0.09M	0.09M
Change in Working Capital
Change in Receivables (Quarter)	-0.08M	0.07M	0.09M	0.14M	-0.09M	0.10M	0.10M	0.12M	-0.10M	-0.52M	0.04M	0.09M	0.10M	0.06M	0.17M	0.15M	-0.37M	0.12M	-0.27M	-0.07M
Change in Accured Expenses (Quarter)	0.03M	-1.16M	0.99M	0.84M		-0.03M	1.36M	-1.37M	0.20M	1.09M	0.14M	1.40M	1.42M	0.67M	-0.00M	0.90M	-1.04M	4.27M	-1.96M	0.94M
Investing Activities
Capital Expenditures (Quarter)		0.03M	0.07M	-0.09M	0.17M	0.31M	0.45M	-0.70M	0.13M	-0.12M	0.56M	0.01M	0.08M			-0.08M	0.90M	-0.88M	0.02M	0.70M
Sales of Property, Plant and Equipment (Quarter)							0.04M
Acquisitions (Quarter)
Change in Acquisitions & Divestments (Quarter)	2.50M	3.24M	3.24M	19.42M	17.09M	17.80M	16.26M	2.68M	42.98M	25.28M	-58.10M	76.39M	5.63M	6.87M	-2.24M		21.23M	13.79M	-33.78M	69.88M
Cash from Investing Activities (Quarter)	-111.70M	-19.00M	8.05M	-8.79M	18.36M	7.61M	5.16M	7.02M	7.33M	11.48M	3.82M	13.56M	4.64M	14.02M	-9.43M	4.51M	-14.58M	-4.98M	10.16M	10.75M
Financing Activities
Other financing activities (Quarter)		0.80M												0.20M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)
Long-Term Debt Repayments (Quarter)
Change in Capital Stock
Shares Issued (Quarter)	1.26M	17.96M		-17.96M			0.07M						0.11M	1.80M	7.40M	53.05M	0.00M		0.03M	0.47M
Shares Repurchased (Quarter)
Preferred Shares Issued (Quarter)
Dividend Payments
Dividends Paid - Common (Quarter)
Misc.
Cash from Financing Activities (Quarter)	1.26M	19.23M		14.96M			0.07M						0.11M	2.06M	7.43M	44.19M	0.00M		0.03M	2.55M
Exchange Rate Effect (Quarter)
Change in Cash (Quarter)	-116.32M	-4.08M	2.58M	-1.22M	8.11M	0.91M	-2.25M	-2.37M	-1.33M	4.35M	-4.14M	6.42M	-3.00M	6.84M	-12.46M	38.43M	-27.38M	-13.31M	-0.65M	7.33M
Free Cash Flow (Quarter)	-5.88M	-4.33M	-5.54M	-7.30M	-10.42M	-7.01M	-7.93M	-8.69M	-8.79M	-7.01M	-8.52M	-7.15M	-7.82M	-9.23M	-10.46M	-10.19M	-13.70M	-7.45M	-10.85M	-6.67M
Net Cash Flow (Quarter)	-116.32M	-4.08M	2.58M	-1.22M	8.11M	0.91M	-2.25M	-2.37M	-1.33M	4.35M	-4.14M	6.42M	-3.00M	6.84M	-12.46M	38.43M	-27.38M	-13.31M	-0.65M	7.33M

Research Tools

Cardiff Oncology Cash Flow Statement (2011-2025) | CRDF

Create an account

Sign In

Reset Password